Sales and Marketing

Showing 15 posts of 11527 posts found.

Roche buys French biotech for €470 million

January 19, 2015 Sales and Marketing Foundation, Genentech, Orphan, Roche, TRO19622, olesoxime, sma, trophos

Roche is buying France-based biotech Trophos in a deal worth up to €470 million in order to gain access to …

Astellas takes senior head from AstraZeneca

January 19, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, AstraZeneca, eric Terhaerdt

Eric Terhaerdt has been named as the senior vice president of global development operations at Astellas Pharma. Terhaerdt, who joins the …

Interview: Rajeev Venkayya, president of Takeda Vaccine

January 19, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bush, Ebola, Gates, Rajeev Venkayya, Takeda, brett wells, vaccines

 Rajeev Venkayya is the president of the global vaccine business unit at Takeda Pharmaceuticals. He has served as special assistant …

GSK double complaint ruled out by PMCPA

January 16, 2015 Medical Communications, Sales and Marketing ABPI, COPD, GSK, PMCPA, Relvar, Seretide

Complaints questioning the promotion of two of GlaxoSmithKline’s chronic obstructive pulmonary disease (COPD) drugs have been ruled out by a …

FDA approves novel obesity device

January 16, 2015 Medical Communications, Sales and Marketing EnteroMedics, FDA, Novo, VBLOC, diabetes, obesity, type 2

The US Food and Drug Administration has shown the green light to US firm EnteroMedics’ new obesity device VBLOC that …

MedDay appoints senior head from Sanofi

January 16, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Philippe Goupit, Sanofi, medday

Paris-based biotech MedDay has appointed Philippe Goupit as an independent non-executive director. Goupit was until recently the vice president of …

CDF chair: more treatment reviews to come

January 16, 2015 Sales and Marketing CDF, Cancer Drugs Fund, NHS, NHS England, NICE, peter clark

The chair of NHS England’s cancer drugs fund has said there is likely to be more reviews of affordable treatments …

Janssen privy to new pricing scheme and see NICE nod

January 16, 2015 Sales and Marketing Janssen, NHS, NICE, hep C, hepatitis, olysio, ribavirin, simeprevir

Janssen’s hepatitis C drug Olysio has been approved by NICE whilst also reaching a novel ‘pay if you clear’ pricing …

NICE approves Sovaldi

January 16, 2015 Sales and Marketing Gilead, NHS, NICE, hep C, hepatitis, pharma, sofosbuvir, sovaldi

NICE has recommended Sovaldi in final draft guidance and extended its scope, despite concerns over the price of the blockbuster …

Boehringer complaint ruled out by PMCPA

January 15, 2015 Medical Communications, Sales and Marketing ABPI, Boehringer, COPD, PMCPA, Striverdi, olodaterol

A complaint made by a pharmacist stating that the artwork image for Boehringer Ingelheim’s COPD drug Striverdi is misleading has …

Sanofi and Boehringer partner on biologics manufacturing

January 15, 2015 Manufacturing and Production, Sales and Marketing Boehringer, Sanofi, antibodies, biologics, cardiovascular, diabetes, mabs, manufacturing, monoclonal, oncology

Boehringer Ingelheim will help Sanofi extend its manufacturing capabilities for biologics in a new alliance, the companies have announced. Boehringer’s …

Sharing trial data should be ‘expected norm’ says US think-tank

January 15, 2015 Medical Communications, Research and Development, Sales and Marketing FDA, Goldacre, Institute of Medicine, clinical trials, transparency

Clinical trial data is in the public interest and should be shared no less than 30 days following regulatory approval …

NICE releases reflux disease guidelines

January 15, 2015 Sales and Marketing NHS, NICE, UK, gor, gord, h2ra

NICE has released new guidelines providing doctors with advice on how to treat gastro-oesophageal reflux disease (GORD) in young people. …

HSCIC appoints new specialist

January 15, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HSCIC, andy kinnear

The Health and Social Care Information Centre (HSCIC) has appointed Andy Kinnear as a specialist. He will join the organisation …

AstraZeneca’s troubled Brilinta gets welcome lift

January 14, 2015 Sales and Marketing AstraZeneca, Brilinta, FDA, US Department of Justice, acute coronary syndrome, ticagrelor

AstraZeneca has reported positive primary endpoint results for its anti-clogging drug Brilinta to treat patients who have had a heart …
The Gateway to Local Adoption Series

Latest content